- Staat
- OH
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cataplexy
Dyskinesia
Eye movement disorder
Fatigue
Hyporesponsive to stimuli
Loss of consciousness
Musculoskeletal stiffness
Pallor
Symptomtext
Child here for school vaccines. Discussed Tdap, Meningitis and HPV vaccines. No contraindications noted. Today received Tdap, menactra and HPV vaccines. After she received vaccines she walked across room to sit down in another chair and within 1 minute of vaccines child became pale, body started to go limp in chair. Called for help, child was limp in chair, eyes rolled back in head, child lost brief consciousness @ 10-15 seconds, nurse was standing in front of child. Once child regained consciousness, her body stiffened and she had a brief jerky movement of her upper and lower extremities lasted only a few seconds. Dr. (clinic medical director) was in the room, supporting child's head. Child was slow to respond to questions asked. Laid her down on clinic bed. BP 90/42 HR @80. Ice pack applied to forehead. Child was able to answer basic questions but slow to respond. Had her drink some juice and laid in clinic bed for 30 minutes after incident. BP 115/50 HR @80. Dr. and RN spoke with mom. Dr discussed that child may have had a seizure and that she needs to be seen by her doctor for follow up and consult with neurologist for possible further testing. Mom asked appropriate questions and agreed to do the follow up. Child slowly became more awake and alert after lying down for over 30 minutes. Child stated that she felt tired but was able to verbalize and stand up and walk. Dr assessed child and was ok with child leaving to go home with mom. Walked with child and mom to the car. Child was back to herself and feeling better. Received mom's info to follow up with her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Penicillin (rash)
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 21.10.2021
- Impfdatum
- 21.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Loss of consciousness
Nervousness
Syncope
Symptomtext
Immediately after receiving vaccinations, client fainted. He lost consciousness for approximately 45 seconds then regained consciousness. Client remained upright in the chair and no injury occurred. He drank water and ate crackers. Client and his mother reported he did not eat breakfast that morning and needles "made him nervous". After 15 minutes of close observation client was feeling "back to normal" and his mother drove him home. They were advised to have him eat more and watch for any other abnormal symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- U
- Eingang
- 01.09.2021
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Dizziness
Dysstasia
Orthostatic hypotension
Presyncope
Symptomtext
patient had near syncopal episode after vaccines. patient had orthostatic hypotension. patient did not eat before vaccines, found to have accu-check 78. Felt better after poptart. Patient went with EMS since was not able to stand without feeling symptomatic & dizzy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- BP: 98/60, 96/58, 101/59, 122/70, 112/66, 97/59 accu-check 78
- Aktuelle Erkrankungen
- NONE KNOWN
- Vorgeschichte
- NONE KNOWN
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Flushing
Hyperhidrosis
Loss of consciousness
Pallor
Symptomtext
Pt. received her coivd vaccine, menactra, and tdap shot on 08/12/21. At 11:38 Am the Pt passed out for 30 seconds. pt. was very pale, diaphoretic, and stated she felt flushed. After the pt. came to the nurse took her vitals which were Bp92/60, HR97, O2 98%. The nurse had pt. lie down for a few minutes and gave her some food and water. At 11:57 Am the pt. passed out again for 30 seconds and came to. The nurse immediately laid the patient down and took her vitals. BP98/70, HR 53, O2 99%. Pt. was pale, diaphoretic and felt flushed. The nurse offered her more food and water and retook the vitals at 12:07 Pm Bp98/70, HR90, O2 98%. Pt. was able to leave at 12:44 Pm. F/U 8/13/21 no subsequent events, pt. was fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- No medications
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 10.08.2021
- Impfdatum
- 03.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test
Dehydration
Electrocardiogram normal
Fatigue
Loss of consciousness
Electrocardiogram
Eye movement disorder
Mydriasis
Oxygen saturation decreased
Pallor
Posture abnormal
Skin discolouration
Urine analysis
Symptomtext
Eyes dilated, skin was ashy, lips turned white, eyes rolled up in head, passed out. Called 911. Oxygen level was 84%, gave supplemental oxygen until paramedics arrived. In route to hospital IV fluids were started and continued with 1000ml at hospital. Stayed at hospital for the day for monitoring. Discharged late afternoon. Very very tired for several days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- EKG, Blood and urine labs, oxygen and blood pressure monitoring. Following up with primary doctor next week.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Concerta 27 mg in morning and 3mg Melatonin before bed.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 10.08.2021
- Impfdatum
- 09.08.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
After being vaccinated, the patient walked to the cashier with his father to check out. As they were waiting, the patient fainted. The father caught him before he hit the floor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- Unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 06.08.2021
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Nausea
Pallor
Presyncope
Symptomtext
Client is a 11 year old female that presented to the immunization clinic for Tdap, HPV9, and MCV4 vaccine. Client was called back to vaccination area around 0930. Client reported no vasovagal hx-confirmed w/ mother. This writer administered Tdap vaccine & client began to lean over in chair. This writer & mother supported client. Client reported feeling "nauseous & tired." This writer explained to client that she had experienced a vasovagal reaction. Client was able to tell this writer name, DOB, and location. This writer asked co workers for assistance. Co-worker obtained ice pack for client because she reported feeling hot. This writer obtained trash can (reported feeling nauseous) & began to fan the client. This writer noted client's lips/ skin were pale. Client reported eating & drinking this morning prior to appointment. Client reported feeling "slightly better." Client was transported to bed in clinic area by nursing staff (co-workers & this writer). Client was provided water & saltine crackers. Client was encouraged to raise legs to increase blood flow. This writer noted client's lips/skin returned to normal color. Client reported feeling better & stated "I am ready for the next vaccines." This writer explained that client would need to remain lying down for next two injections. Client and mother verbalized understanding. This writer administered MCV4 & HPV9 with no issues. Client was encouraged to stay lying down for 15 minute wait. Client waited 15 minutes & reported feeling "good." Client & mother were observed walking out of clinic @ 1015. This writer encouraged mother to inform future vaccinators of vasovagal hx of client, so vaccines can be given lying down.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 30.07.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
A few minutes after receiving his vaccinations and as I was finishing up freezing his wart on his hand, patient passed out. Fortunately, I was still close to him when it happened and I was able to catch him so he didn't injure himself. I layed him down and he came to within a few seconds. Pulse ox was placed on him and ranged from 96-98 with HR in the 80's. After a few minutes, he felt well enough to sit up. He was given a cup of water and goldfish which he tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- One viral wart treated just prior to vaccination via liquid nitrogen and one viral wart treated after vaccination with liquid nitrogen.
- Vorgeschichte
- ADHD
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pallor
Syncope
Symptomtext
after vaccination pt became very pale in office, near syncope. laid down and observed for 20 minutes after injections and then was fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal behaviour
Asthenia
Blood pressure increased
Dizziness
Pallor
Presyncope
Pulse abnormal
Thinking abnormal
Symptomtext
patient had a near syncope event after administration of vaccines. Gardasil administered last in left arm. Patient seemed weak and was moved from exam table to chair,felt dizzy and became quiet and pale, difficulty answering questions. Legs were elevated on a chair, pt was given water to drink but only took a few sips, eyes were closing and could not hold cup of water. Weak radial pulse noted, systolic BP ~ 80 (was initially 100 at start of visit). Patient was monitored for approx 5 more minutes, after which time she said she felt better, pulses returned to normal, BP back up to 80. entire episode lasted ~ 10 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 16.07.2021
- Beginn
- 16.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Head injury
Loss of consciousness
Seizure
Skin laceration
Symptomtext
BP 98/60 at time vaccines administered After vaccines patient and mother stayed in the room for 3 to 4 minutes, then walked out in hallway towards exit door but patient fell unconscious hit her head against edge of counter wall, had a 10 second seizure and within 30 seconds became alert and responsive, not sleepy or drowsy Pt was taken in wheelchair back to exam room laceration noted on scalp occipital area, gauze given to stop bleed. Pressure applied EMS 911 called and paramedics arrived 7 minutes later, BP 149/90 and taken to ER Pt is better still with staple stitches on scalp Per mom. To follow up here expected 7/23/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- obesity/ menometrorrhagia
- Vorgeschichte
- None known or reported on history
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Crying
Gaze palsy
Generalised tonic-clonic seizure
Loss of consciousness
Symptomtext
Shortly after vaccines were given, Patient's eyes rolled back in her head. Mom laid her down on the table and she passed out. She had a brief tonic clonic seizure that involved all 4 extremities and lasted a few seconds. By the time the physician entered the room, she was awake and crying. Within 15 minutes, Patient was able to walk out of the office with her mom.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Generalised tonic-clonic seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- food allergies
- Andere Medikamente
- Claritin
- Allergien
- peanuts, tree nuts, pineapple, bananas
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 16.07.2021
- Impfdatum
- 16.07.2021
- Beginn
- 16.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Syncope
Symptomtext
Client fainted after receiving her vaccinations. She fell to the floor from a seated position. Client came to immediately after fainting and falling. Client was given ice packs to cool her off, peanut butter crackers, and water. Vitals were monitored. No injuries noted. Client left with mother after being observed in clinic for further reactions. Client states that she felt better and appeared to have completely recovered at the time of leaving clinic. I will contact client's mother this afternoon to check on her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 14.05.2021
- Impfdatum
- 14.05.2021
- Beginn
- 14.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
Patient fainted about 5-10 minutes post injection. I'm unaware of her symptoms leading up to the syncope.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- EMS came and took pt's vitals. She was cleared to leave after about 30 minutes more or less.
- Aktuelle Erkrankungen
- unknown.
- Vorgeschichte
- unknown
- Andere Medikamente
- Unknown
- Allergien
- None.
- Vorherige Impfungen
- Feels faint/dizzy
- Staat
- OH
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 11.11.2021
- Impfdatum
- 10.11.2021
- Beginn
- 10.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Injection site pain
Injection site pruritus
Urticaria
Wound
Symptomtext
left arm approx 5inches from injection site because very itchy, developed hives, and multiple blisters. The blisters coalesced into a single large bullae and broke open on 11/11/2021 leaving a 5-6 cm area denuded, tennis ball sized injection site is only mildly tender no issue on right arm with where tdap and menactra were given no systemic signs of illness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none other family members had covid, he was asymptomatic and tested negative
- Vorgeschichte
- eczema, moderate persistent asthma w/o complication, pediatric obesity BMI> 95% for age, ADHD, chronic PTSD
- Andere Medikamente
- zyrtec 10mg, adderall 5mg po daily, singulair 5mg po daily, clonidine , intuniv 3mg po daily
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 20.09.2021
- Impfdatum
- 14.09.2021
- Beginn
- 15.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dry skin
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
The injection site of varicella @ left upper arm has redness, swollen, skin is rough , it is warm to touch, size 4.5cm x 5.0 cm, but no fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 11.09.2021
- Impfdatum
- 24.08.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Injection site pruritus
Injection site rash
Rash papular
Vaccination site pruritus
Vaccination site rash
Symptomtext
papular rash with itchiness on the right deltoid where the ADACEL injection was given, papular rash on the left deltoid where the MENACTRA was given as well as a less prominent rash on the left forearm where the TUBERSOL was administered; papular rash with itchiness on the right deltoid where the ADACEL injection was given; 0.2 ml tubersol administered; Initial information received on 27-Aug-2021 regarding an unsolicited valid non-serious case from a physician via Information (Reference number- 00744329). This case is link to the 2021SA288844 and 2021SA286572 (same reporter). This case involves a 11-year-old male patient who had papular rash with itchiness on the right deltoid where the DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] injection was given, papular rash on the left deltoid where the MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was given as well as a less prominent rash on the left forearm where the TUBERCULIN TEST [TUBERSOL] was administered pruritus (vaccination site rash, vaccination site pruritus). The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 24-Aug-2021, the patient received a first dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (Injection, 0.5 ml, lot U6767AA and expiration date: 31-Jul-2022) via intramuscular route in the right deltoid for prophylactic vaccination; a first dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (0.5 ml, lot U6951AA and expiration date: 06-Jun-2022) via intramuscular route in the left deltoid for prophylactic vaccination and a first dose of TUBERSOL (TUBERCULIN TEST) (Solution for injection, 0.2 mL in total, lot - C5806AA and expiration date:25-Mar-2023) via intradermal route in the left forearm for tuberculin test. It was a case of drug overdose (overdose, same day latency), as 0.2 ml tuberculin test was administered. On an unknown date, the patient developed a non-serious papular rash with itchiness on the right deltoid where the DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] injection was given, papular rash on the left deltoid where the MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was given as well as a less prominent rash on the left forearm where the TUBERCULIN TEST [TUBERSOL] was administered pruritus (vaccination site rash, vaccination site pruritus) [unknown latency]. It was reported "Doctor states that a patient was seen in her office on 24-Aug-2021 and received injections of ADACEL, MENACTRA, and TUBERSOL during this visit. Doctor states that patient returned to office on 26AUG2021 to have the TUBERSOL results read and the patient's caregiver mentioned rashes that had formed in the areas where the vaccinations were given. The patient had a papular rash with itchiness on the right deltoid where the ADACEL injection was given. The patient also had a papular rash on the left deltoid where the MENACTRA was given as well as a less prominent rash on the left forearm where the TUBERSOL was administered. Doctor stated that she was unsure if this needed to be reported to safety and called Information to be safe. Doctor also asked whether she needed to contact the Vaccine Adverse Event Reporting System as well. Doctor states that the VAERS (vaccine adverse reporting system)website referred her to the package inserts of each product." No laboratory data reported. It was not reported if the patient received a corrective treatment. At time of reporting, the outcome was unknown for all the reported events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TUBERSOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 08.09.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Pallor
Symptomtext
- He felt dizzy and nauseous after he got vaccinations. On exam was pale. Was taken to exam room and kept on exam table. He felt better and repeat B.P was 102/72 mm Hg. Lungs were clear; CVS exam was normal. Pulses were full and regular. Stayed in exam room for about 25 minutes for observation and was sent home..
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- -
- Allergien
- house dust mites oak bark orange peel
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 07.09.2021
- Beginn
- 07.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Gait disturbance
Headache
Posture abnormal
Tinnitus
Unresponsive to stimuli
Symptomtext
Female was sitting with mom for the 15 minutes and mom yelled that her head went back and did not respond. She was alert when I came out but stated ears were ringing and had a headache. Layed her on the floor with legs elevated and cold cloth to neck. After 6 minutes sat her up and she stated she was fine. Staff escorted her out with mom and she was walking not in a straight line. She had stated that she had not had any breakfast prior to coming for the injection. Mom was going to keep her home for the rest of the day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 04.09.2021
- Impfdatum
- 24.08.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site mass
Injection site pain
Injection site warmth
Symptomtext
injection sites are pretty sore with good size lumps; injection sites are pretty sore, hot and red; injection sites are pretty sore; injection sites red; injection sites hot; Initial information regarding an unsolicited valid non-serious case was received from consumer/non-hcp (Healthcare Professional) via Medical Information (Reference number- 00742744) and transmitted to Sanofi on 26-Aug-2021. This case involves an 11 years old female patient who experienced "injection sites are pretty sore with good size lumps" (vaccination site mass) and "injection sites are pretty sore, hot and red" (vaccination site inflammation, vaccination site erythema, vaccination site pain and vaccination site warmth) after receiving vaccines DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 24-Aug-2021, the patient received a 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6951AA and expiry date: 06-Jun-2022) via unknown route in the right deltoid for prophylactic vaccination. On 24-Aug-2021, the patient received a 0.5 mL dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot U6964AA and expiry date: 19-Feb-2023) via unknown route in the left deltoid for prophylactic vaccination. On 24-AUG-2021 the patient developed a non-serious events "injection sites are pretty sore with good size lumps" (vaccination site mass) and "injection sites are pretty sore, hot and red" (vaccination site inflammation, vaccination site pain, vaccination site erythema and vaccination site warmth), on same day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. It was reported "Caller states she has received allergy shots that were a lot worse but didn't mention any names." Laboratory data was not reported. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for all the reported events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 03.09.2021
- Impfdatum
- 24.08.2021
- Beginn
- 26.08.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pruritus
Injection site rash
Rash papular
Tuberculin test
Symptomtext
non erythematous papular rash clustered around vaccination sites within 2 days and itchy at only Tdap site also
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- ppd test applied at same visit on left lower forearm
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 26.08.2021
- Impfdatum
- 11.08.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Eye disorder
Pallor
Symptomtext
CLIET SEATED FOR IMM. NO HX OF VACCINE REQ. FOR SCHOOL. AFTER BECAME PALE WITHOUT C/O. ADMITTED TO LIGHT HEADEDNESS WHEN ASKED. NO DIAPHORESIS, LOC, CHANGE IN EYE. HELPED TO EXAM TABLE. DECREASED AOB & INCREASED FOB. 144PM - 90/60. 1:50PM 100/70. P 80. NO FURTHER LIGHTHEADEDNESS OR COLOR CHANGE. TOLERATED SITTING THEN STANDING/WALKING WITHOUGH ANY S/S. DISCUSSED FUTURE IMM & POS. ETC.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- ONLY A COLD
- Vorgeschichte
- NO
- Andere Medikamente
- NONE
- Allergien
- LATEX BANDAGE
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 18.08.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Feeling hot
Headache
Injection site erythema
Injection site oedema
Injection site pain
Pyrexia
Swelling
Urticaria
Symptomtext
Patient describes initial symptoms around 8 pm, headache, feeling feverish, local pain, erythema and edema on site of Menactra injection. Same night she developed hives and felt very hot. She reports that she took Acetaminophen some time after feeling hot and to help with headache. She did not visit any facility to get treatment and neither called my Office, she reports that fever subsided by next day, the swelling was present for about 2 days and the hives were improving and recurring for about 2 weeks. Symptoms have subsided and did not recur after 2 weeks of injection. She came today for second Bexsero appt but declined vaccine and described symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- none - she did not seek medical care
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 18.08.2021
- Impfdatum
- 17.08.2021
- Beginn
- 17.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
After administering the vaccines the client stated he was feeling dizzy, he was assisted to lying position on the ground, pillow behind head, bilateral lower extremities elevated, cold pack to forehead and nape of neck, pulse and blood pressure checked. After 30 minutes client was assisted to sitting position in a chair and monitored for an additional 20 minutes. Client states he felt better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- No labs collected.
- Aktuelle Erkrankungen
- Unknown.
- Vorgeschichte
- Unknown.
- Andere Medikamente
- Unknown.
- Allergien
- Unknown.
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 06.08.2021
- Impfdatum
- 28.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dysphonia
Lip swelling
Oropharyngeal discomfort
Rash
Tongue pruritus
Symptomtext
Rash on face and neck, swollen lips, itchy tongue, voice alteration and throat discomfort.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 21.07.2021
- Impfdatum
- 17.07.2021
- Beginn
- 17.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hyperhidrosis
Pallor
Vomiting
Symptomtext
Patient became diaphoretic, pale, felt faint and vomited a small amount/ BP 94/54.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 03.06.2021
- Impfdatum
- 02.06.2021
- Beginn
- 02.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Auditory disorder
Dysgeusia
Ear discomfort
Head discomfort
Injection site discomfort
Limb discomfort
Pallor
Visual impairment
Symptomtext
A few minutes after administering the shot, patient stated she was having visual changes, auditory changes, her limbs felt very heavy, and she was very pale. An ice pack was placed on the back of her neck and she was given a bottle of water. After about 10 minutes she said her vision was improving and her limbs felt better. She also stated that she had a metallic taste in her mouth and she felt pressure in her head, mainly around her ears. I continued to fan her to try and cool her down. She stated that she was feeling better but still had slight pressure in her ears after about 25 minutes after shot was given. After 35 to 40 minutes she said her vision was good, her limbs felt ok (except for some heaviness at injection site on arm), the pressure in her head was better, but she still had the metallic taste (but it had gotten much better). Patient's mother was with her and we talked to her the whole time she was having the event. After about 45 minutes, she was able to stand up and stated that she felt good. I followed up about 2 hours later with her mother and she stated that patient was feeling much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discomfort
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 09.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Menactra was administered after expiration with no reported adverse event; Initial information received on 02-Aug-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 18 years old male patient to whom MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was administered after expiration with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Aug-2022, the patient received as indicated dose 2 (booster) of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE, (frequency: once) ( lot: U6951AA ; expiry date: 06-Jun-2022) via intramuscular route in the deltoid nos for immunization. It was reported that Menactra was administered after expiration with no reported adverse event (expired product administered) (latency: same day) Action taken : Not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 09.07.2022
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
they inadvertently gave expired MENACTRA to a patient, with no reported adverse event; Initial information received on 01-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 17 years old female patient who while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and it was reported that they inadvertently gave expired menactra to a patient, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Jul-2022, the patient received a dose of 0.5 ml of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6951AA, expiration date: 06-Jun-2022, (strength: unknown) with Intramuscular route in the left deltoid as Immunisation. On 01-JUL-2022, they inadvertently gave expired menactra to a patient, with no reported adverse event (expired product administered) same day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Still using product : No Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (they inadvertently gave expired MENACTRA to a patient, with no reported adverse event). At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 20.06.2022
- Impfdatum
- 08.06.2022
- Beginn
- 08.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
patient was administered an expired dose of Menactra with no reported adverse event; Initial information received on 09-Jun-2022 regarding an unsolicited valid non-serious case received from another health professional. This case involves a 25-year-old female patient who was administered an expired dose of menactra with no reported adverse event while receiving vaccine meningococcal a-c-y-w135 (d conj) vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Measles Vaccine, Mumps Vaccine, Rubella Vaccine (MMR) for Prophylactic vaccination. On 08-Jun-2022, the patient received a 0.5 ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine lot U6951AA expiration date 06-Jun-2022 via intramuscular route in the left deltoid for prophylactic vaccination. The patient was administered an expired dose of menactra with no reported adverse event (expired product administered). Action taken: Not applicable Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 17.06.2022
- Impfdatum
- 08.06.2022
- Beginn
- 08.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
expired dose of MENACTRA was given today with no adverse events; Initial information was received on 08-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a 20 years old male patient who experienced expired dose of menactra was given today with no adverse events while receiving vaccine meningococcal A-C-Y-W135 (D CONJ) vaccine [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 08-Jun-2022, the patient received a dose of suspect menactra (lot U6951AA) (dose, formulation, strength and expiry date: unknown) via intramuscular route in the right deltoid for immunisation. On 08-JUN-2022 the patient developed a non-serious expired dose of menactra was given today with no adverse events (expired product administered) (latency same day) following the administration of menactra. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event expired dose of menactra was given today with no adverse events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
nurse administered a MENACTRA vaccine one day after the expiration date, with no adverse event; Initial information received on 08-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 17 years old female patient to whom nurse administered a MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] vaccine one day after the expiration date, with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE B (MENB) for Prophylactic vaccination. On 07-Jun-2022, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6951AA; expiry date: 06-Jun-2022, strength, expiry date: unknown) solution for injection at a dose of 0.5 ml total via intramuscular route in the deltoid as Immunization. On 07-Jun-2022, the nurse administered a MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE one day after the expiration date, with no adverse event (expired product administered) (latency: same day). He asked if it needs to be repeated. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event nurse administered a menactra vaccine one day after the expiration date, with no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- MENB
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient received vaccination one day after vaccine expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Sertraline 50 mg tablet PO daily, Norethindrone-estradiol-iron 1 mg-10 mcg-10mcg PO daily, Albuterol sulfate inhaler
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Menactra booster dose was given at 14 years age with no reported adverse event; Initial information received on 01-Feb-2022 regarding an unsolicited valid non-serious case was received from the health professional. This case involves a 14 years old female patient to whom meningococcal a-c-y-w135 (d conj) vaccine (Menactra) booster dose was given at 14 years age with no reported adverse event. The patient's past medical history, medical treatment(s), and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) for Prophylactic vaccination. On 01-Feb-2022, the patient received a booster dose of suspect meningococcal a-c-y-w135 (d conj) vaccine at 0.5 ml total (lot number: U6951AA) via intramuscular route in right deltoid for immunization (product administered to patient of inappropriate age) (latency: same day). Reportedly, the patient was inadvertently administered a booster dose of meningococcal a-c-y-w135 (d conj) vaccine too early. Healthcare professional asked if there was any special to watch for in terms of safety or if there was any information on the validity of a dose given early and in response to the information provided in the "Booster Dose" SRD, whether it means in this case that the child could get the Menactra booster dose "when the child reaches at least the minimum age" or since this inadvertent dose was given at 14, would the patient have to wait 3 years until age 17 before getting a Menactra booster, since "the repeat dose should be spaced after the invalid dose by the recommended minimum interval." HCP stated that she had spoken to the patient's mother about three hours after the inadvertently dose, and the patient was fine and not experiencing any issues so far. Action taken with meningococcal a-c-y-w135 (d conj) vaccine was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 13.10.2021
- Impfdatum
- 24.09.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
The patient is an unaccompanied minor and received a first dose Pfizer Covid-19 immunization on route 9/12/2021. There was no vaccine record accompanying the child. Upon arrival the child shared he had received vaccines prior, but thought he had "measle and chickenpox vaccines". Even with the aid of an interpreter he did not mention Covid or polio. MMR, Varicella and Covid vaccines are required to be administered within 48 hours of arrival. Child arrived on 9/22/2021 and was vaccinated (with all catchup ACIP vaccines including Covida and Polio) on 9/24/2021 (12 days after 1st Covid dose) less than the 21 day requirement for Covid 2nd doses. We are adhering to the CDC Deviations and Errors guidelines and will not administer a 2nd dose. The child had MMR/Varicella /Polio/Covid on 9/12/2021 and the vaccination record was not received until 10/13/2021. No MMR or Varicella were given on 2/24/2021 as we had been informed that MMR/Varicella had been administered. No adverse reactions at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.09.2021
- Impfdatum
- 25.08.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
9 patients received MENACTRA post-excursion at negative 0.7 degree Celsius for 5 minutes/ no AE;Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Medical Information (Reference number- 00750950) and transmitted to Sanofi on 01-Sep-2021. This case is linked to case Id: 2021SA293642 (CLUSTER). This case involves 9 patients (unknown demographics) who had received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot U6951AA, expiry date 06-Jun-2022) post-excursion at negative 0.7 degree Celsius for 5 minutes (product storage error) via unknown route at an unknown administration site on 25-Aug-2021 for prophylactic vaccination. It was a case of potential medication error due to product storage error temperature too low (latency was on same day). At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.09.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
vaccine were exposed to 19.8 Fahrenheit and were out of range for 2 hour and 16 minutes/no ae; Initial information received on 10-Sep-2021 regarding an unsolicited valid non-serious case received from a other health care professional via under Medical Information Inquiry Number: 00764523. This case is linked to case US-SA-2021SA303376(CLUSTER). This case was considered as non-valid due to no involvement of patient. This case involved vaccines IPV (VERO) (lot number: R1F973M and expiry date: 10-MAR-2021), (lot number: T1E871M and expiry date: 10-OCT-2022), (lot number: T1D482M and expiry date: 25-FEB-2022), (lot number: R1F97 and expiry date: 10-MAR-2021), (lot number: T1E87 and expiry date: 10-OCT-2022) HIB (PRP/T) VACCINE (lot number: UJ661AAA and expiry date: 05-JUN-2022), (lot number: UJ526AAA and expiry date: 06-MAR-2022), (lot number: CC5788BA and expiry date: 14-OCT-2022) DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (lot number C5829BA and expiry date: 03-JAN-2031) DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot number: UJ528AAA and expiry date: 07-OCT-2022), (lot number: UJ435AAA and expiry date: 17-MAY-2022), (lot number: UJ421AAA and expiry date: 03-AUG-2022) DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number: CC5788BA and expiry date: 07-OCT-2022) MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number: U6951AA and expiry date: 06-JUN-2022) that were exposed to negative 19.8 degrees Fahrenheit degree for an undetermined period (product storage error). It was potential medication error case due to product storage error temperature too low. It was reported "Caller stated they had a temperature excursion of unknown cause". At the time of reporting, no adverse event was reported This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 17.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
administered at 256 no reaction noted and discharged at 311
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- NO KNOWN ALLERGIES
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- ~COVID19 (COVID19 (Pfizer-BioNTech))~1~12.00~Patient
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- U
- Eingang
- 05.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No Adverse reaction Expired IPV 7/16/21 given 8/2/21 IPV will be reoeated 30 days after 8/2/21 vaccines Mother Ntfd.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- UNKNOWN
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 30.07.2021
- Impfdatum
- 25.05.2021
- Beginn
- 25.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incomplete course of vaccination
Product administered to patient of inappropriate age
Symptomtext
Father completed paperwork indicating client was 12 yrs of age, correct DOB 9/21/2009 given also at time of registration. Nurse preparing vaccine noted age as 12 as indicated by father and did not calculate age using DOB. Pfizer COVID vaccine offered to parent and accepted. COVID and other vaccines administered. Client returned with parent at appropriate time for second dose. Nurse administering vaccine at that time noted age was 11 yrs. and vaccine not given and why. Mother contacted office the following day to discuss COVID being given. Mother informed according to current CDC guidelines, dose # 1 was valid and that second dose should be given when the client turns 12 yrs of age. Mother also told that if CDC guidance changes she would be contacted. Mom verbalized understanding
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incomplete course of vaccination
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None noted on Health Questionnaire
- Vorgeschichte
- None noted on Health Questionnaire
- Andere Medikamente
- Not known
- Allergien
- None noted on Health Questionnaire
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 29.06.2021
- Impfdatum
- 28.06.2021
- Beginn
- 28.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Fall
Hyperhidrosis
Pallor
Symptomtext
Shortly after vaccination client became pale and diaphoretic and fell from chair possible short LOC, weak, HR 68, BP 79/50
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None known
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -